What is INFIGRATINIB used for?

INFIGRATINIB is studied for treating various cancers, including bladder cancer, cholangiocarcinoma, melanoma, and glioblastoma.

How does INFIGRATINIB work in the body?

This drug acts as a fibroblast growth factor receptor inhibitor to target specific pathways.

Is INFIGRATINIB taken by mouth?

Yes, INFIGRATINIB is an oral medication.

What types of cancer is INFIGRATINIB being researched for?

Research includes its use for urinary bladder cancer, cholangiocarcinoma, melanoma, and glioblastoma.

Has INFIGRATINIB been approved for use?

The data indicates it has reached a maximum phase of 4.0, but specific FDA approval status for a single indication is not detailed.

What is the chemical formula for INFIGRATINIB?

The chemical formula for INFIGRATINIB is C26H31Cl2N7O3.

infigratinib | CAS 872511-34-7 | QADPYRIHXKWUSV

Loading compound...

Fibroblast growth factor receptor inhibitor

INFIGRATINIB is a small molecule drug that works as a Fibroblast growth factor receptor inhibitor. It is used in research and clinical studies for various conditions, including certain types of cancer like bladder cancer and cholangiocarcinoma.

How it worksINFIGRATINIB works by blocking fibroblast growth factor receptors in the body.

Used for

CancerUrinary bladder cancerCholangiocarcinomaGlioblastoma multiformeMelanoma

Conditions

Urinary bladder cancerCholangiocarcinomaGlioblastoma multiformeMelanoma

Class

Small moleculeFGFR inhibitorFibroblast growth factor receptor inhibitorUrinary systemSkinNervous system

How to take

FormsOral

RoutesOral

Information regarding specific dosing and administration instructions is not available in the provided data bundle.

Talk to your doctor

Questions to ask

·How does INFIGRATINIB work for my specific type of cancer?
·What are the expected results of taking INFIGRATINIB?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)